Alvogen Lux Holdings acquired 210,000 shares in Alvotech, reported to Luxembourg's CSSF.
Quiver AI Summary
A press release has been issued about a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) concerning transactions by managers and closely associated persons. It announces that Alvogen Lux Holdings S.ár.l., the second largest shareholder in Alvotech, has acquired 210,000 shares at ISK 1,277.38 each. The largest shareholders in Alvogen Lux Holdings are CVC with 40%, Aztiq with 30%, and Temasek with 20%.
Potential Positives
- The acquisition of 210,000 shares demonstrates strong confidence from Alvogen Lux Holdings, a significant stakeholder in Alvotech, reinforcing the company's market position.
- Alvogen Lux Holdings is backed by reputable shareholders such as CVC, Aztiq, and Temasek, indicating a solid financial foundation and support network for Alvotech.
Potential Negatives
- Potential concerns about insider trading or the implications of key management acquiring significant shares could raise red flags about transparency.
- The reliance on major shareholders like CVC, Aztiq, and Temasek might indicate a lack of independence for Alvogen Lux Holdings, which could affect investor confidence.
FAQ
What is the recent acquisition by Alvogen Lux Holdings?
Alvogen Lux Holdings announced the acquisition of 210,000 shares in Alvotech at ISK 1,277.38.
Who are the largest shareholders of Alvogen Lux Holdings?
The largest shareholders of Alvogen Lux Holdings are CVC (40%), Aztiq (30%), and Temasek (20%).
What regulatory body was notified about the transactions?
The transactions were filed with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF).
How many shares were acquired by Alvogen Lux Holdings?
Alvogen Lux Holdings acquired a total of 210,000 shares in Alvotech.
What was the acquisition price per share for Alvotech?
The acquisition price per share for Alvotech was ISK 1,277.38.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ALVO Hedge Fund Activity
We have seen 29 institutional investors add shares of $ALVO stock to their portfolio, and 14 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC added 995,538 shares (+31.1%) to their portfolio in Q1 2025, for an estimated $9,626,852
- OAKTREE CAPITAL MANAGEMENT LP removed 606,322 shares (-23.9%) from their portfolio in Q4 2024, for an estimated $8,021,640
- POINTSTATE CAPITAL LP added 484,826 shares (+64.1%) to their portfolio in Q4 2024, for an estimated $6,414,247
- LEGAL & GENERAL GROUP PLC removed 420,869 shares (-42.2%) from their portfolio in Q4 2024, for an estimated $5,568,096
- SCULPTOR CAPITAL LP removed 338,928 shares (-35.9%) from their portfolio in Q4 2024, for an estimated $4,484,017
- MORGAN STANLEY removed 257,272 shares (-14.8%) from their portfolio in Q4 2024, for an estimated $3,403,708
- MILLENNIUM MANAGEMENT LLC removed 107,172 shares (-84.7%) from their portfolio in Q4 2024, for an estimated $1,417,885
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition of 210,000 shares in Alvotech at ISK 1,277.38, by Alvogen Lux Holdings S.ár.l., the second largest shareholder in Alvotech. Alvogen Lux Holdings' largest shareholders are CVC (40%), Aztiq (30%) and Temasek (20%).
Attachment
